Open AccessP540: PEVONEDISTAT, AZACITIDINE AND VENETOCLAX FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA– A PHASE I STUDY
Author(s) -
Guru Murthy G. S.,
Kaufmann S.,
Saliba A.,
Szabo A.,
Michaelis L.,
Abedin S.,
Runaas L.,
Carlson K.,
MaldonadoSchmidt S.,
Hinman A.,
Thomas A.,
Baim A.,
Litzow M.,
Atallah E.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845048.06102.ff
Subject(s) - venetoclax , azacitidine , medicine , myeloid leukemia , oncology , myeloid , salvage therapy , hypomethylating agent , leukemia , myelodysplastic syndromes , gastroenterology , chemotherapy , biology , bone marrow , chronic lymphocytic leukemia , biochemistry , gene expression , dna methylation , gene